- Home
- AMSC vs CPRX Comparison
AMSC vs CPRX Comparison
Compare AMSC & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMSC
- CPRX
- Stock Information
- Founded
- AMSC 1987
- CPRX 2002
- Country
- AMSC United States
- CPRX United States
- Employees
- AMSC N/A
- CPRX N/A
- Industry
- AMSC Metal Fabrications
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- AMSC Consumer Discretionary
- CPRX Health Care
- Exchange
- AMSC Nasdaq
- CPRX Nasdaq
- Market Cap
- AMSC 2.7B
- CPRX 2.6B
- IPO Year
- AMSC 1991
- CPRX 2006
- Fundamental
- Price
- AMSC $57.86
- CPRX $21.36
- Analyst Decision
- AMSC Buy
- CPRX Strong Buy
- Analyst Count
- AMSC 1
- CPRX 5
- Target Price
- AMSC $39.00
- CPRX $33.20
- AVG Volume (30 Days)
- AMSC 1.1M
- CPRX 1.3M
- Earning Date
- AMSC 10-29-2025
- CPRX 11-05-2025
- Dividend Yield
- AMSC N/A
- CPRX N/A
- EPS Growth
- AMSC N/A
- CPRX 183.96
- EPS
- AMSC 0.39
- CPRX 1.65
- Revenue
- AMSC $254,886,000.00
- CPRX $558,499,000.00
- Revenue This Year
- AMSC $28.23
- CPRX $16.59
- Revenue Next Year
- AMSC $11.78
- CPRX $8.80
- P/E Ratio
- AMSC $146.59
- CPRX $12.96
- Revenue Growth
- AMSC 63.73
- CPRX 28.55
- 52 Week Low
- AMSC $13.98
- CPRX $19.05
- 52 Week High
- AMSC $70.49
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- AMSC 48.32
- CPRX 58.18
- Support Level
- AMSC $52.75
- CPRX $20.66
- Resistance Level
- AMSC $61.94
- CPRX $21.52
- Average True Range (ATR)
- AMSC 4.93
- CPRX 0.57
- MACD
- AMSC -0.70
- CPRX 0.06
- Stochastic Oscillator
- AMSC 28.81
- CPRX 88.48
About AMSC American Superconductor Corporation
American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).